Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi ...

This study investigates the molecular mechanisms underlying ligand recognition, subtype selectivity, and activation of ...

For years, people taking one of the world’s most common heart drugs have described the same nagging side effect: sore, aching ...

State-of-the-art technology could accelerate novel drug development, advance precision medicine Intellicule founders Purdue ...

Researchers have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

A new study explains how cholesterol-lowering medications can lead to muscle damage and identifies a possible approach to making these treatments safer. Statins have dramatically improved cardiovascul ...

Intellicule has received a $217,941 NIH SBIR Phase I grant to develop advanced deep-learning software for biomolecular ...

Intellicule, a software company whose solutions determine the 3D structures of biomolecules imaged with cryogenic-electron microscopy (cryo-EM), has received a $217,941 Small Business Innovation ...

Swiss researchers have managed to keep water in a liquid state at surprisingly low temperatures. This research could be useful for scientists working with cryo-electron ...

Glycine is a major inhibitory neurotransmitter that reduces nerve activity, helping to regulate pain signals, motor control ...

Researchers at National Taiwan University have uncovered, for the first time at atomic resolution, how the human proteasome ...